
Aakash Desai/LinkedIn
Jul 1, 2025, 17:49
Aakash Desai: Clinical Outcomes of Perioperative Immunotherapy in Resectable NSCLC
Aakash Desai, Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at the UAB O’Neal Comprehensive Cancer Center, shared a post on LinkedIn about a paper he co-authored with colleagues published in JAMA Network Open:
“Proud to share our recent work in JAMA analyzing real-world patterns and outcomes of perioperative immunotherapy in resectable stage II-IIIA NSCLC, published using the Flatiron Health database.
This is one of the largest US real-world studies on neoadjuvant and adjuvant chemoimmunotherapy, including 1334 patients treated after FDA approvals.
Key findings:
18-month Distant Metastasis–Free Survival (DMFS):
Neoadjuvant cohort: 80.2%
Adjuvant cohort: 83.0%
PD-L1 testing rates:
Adjuvant: 72.2%
Neoadjuvant: 52.6%
Indicates testing gaps in the preoperative setting
Most common metastatic sites:
Brain,
Bone,
Pleura
Patterns were consistent across both cohorts
Use of perioperative IO is increasing, but still underutilized:
Neoadjuvant: from 8.4% (2022) – 13.8% (2023)
Adjuvant: from 19.7% – 22.6%
Why this matters:
Despite compelling survival outcomes, <30% of eligible patients are receiving these treatments.This study underscores the urgent need to:
Expand biomarker testing pre-surgery
Improve multidisciplinary coordination
Address systemic barriers to adoption
Also, read this great commentary by Melina Marmarelis and team.”
Title: Clinical Outcomes of Perioperative Immunotherapy in Resectable Non–Small Cell Lung Cancer
Authors: Aakash Desai, Karen Schwed, Laurynas Kalesinskas, Qianyu Yuan, Jonathan Bryan, Catherine Keane, Erin Fidyk, Emily Castellanos, Aaron B. Cohen, Katherine Harrison, George Ho, Anca Marinescu, Ticiana A. Leal
You can read the Full Article in JAMA Network Open.
More posts featuring Aakash Desai.
Aakash Desai
Aaron B. Cohen
Anca Marinescu
cancer
Catherine Keane
Emily Castellanos
Erin Fidyk
George Ho
immunotherapy
Jonathan Bryan
Karen Schwed
Katherine Harrison
Laurynas Kalesinskas
Lung cancer
non small cell lung cancer
NSCLC
OncoDaily
Oncology
perioperative immunotherapy
Qianyu Yuan
Ticiana A. Leal.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 1, 2025, 16:47
Jul 1, 2025, 16:16